Share Name Share Symbol Market Type Share ISIN Share Description
Malin Corporation Plc LSE:0Y71 London Ordinary Share IE00BVGC3741 MALIN CORPORATION ORD SHS
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.0% 0.00 -
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
- - - - 0

Malin Corporation PLC Update on Litigation by Founder Shareholders

13/10/2021 2:10pm

UK Regulatory (RNS & others)

Malin (LSE:0Y71)
Historical Stock Chart

From Oct 2021 to Dec 2021

Click Here for more Malin Charts.


RNS Number : 9834O

Malin Corporation PLC

13 October 2021

Malin Corporation plc

Malin provides update on Litigation by Founder Shareholders

Dublin-Ireland, 13 October 2021 : Malin Corporation plc (Euronext Growth Dublin:MLC) ("Malin", the "Company") announces, further to the announcement on 8 October 2021, that Irish High Court proceedings have been initiated by the holders of 2,803,801 A Ordinary Shares in the Company ("the Founders") against the Company.

The Founders claim an entitlement to the conversion of their A Ordinary Shares into Ordinary Shares and have reserved their right to apply to Court in the course of the legal proceedings for an Order restraining the Company from implementing any capital returns to ordinary shareholders of Malin pending the conversion. As announced on 8 October 2021, the Company rejected the conversion notices previously submitted to the Company by the Founders, on the basis that no change of control has occurred and the conversion rights carried by A Ordinary Shares are not currently exercisable.

The Board will take all necessary steps to vigorously defend the Company and shareholders against the Founders' proceedings.

The Company remains intent on initiating a significant return of capital to its shareholders by means of a tender offer before the end of 2021.

Further announcements will be made in due course as and when appropriate.


About Malin Corporation plc

Malin (Euronext Growth Dublin:MLC) invests in and supports highly innovative life sciences companies developing exceptional science and technology to deliver transformative outcomes for patients and create significant value for shareholders.

Our purpose is to create shareholder value through the application of long-term capital and strategic support to its investee companies to enable them to reach their value potential. Malin is headquartered and domiciled in Ireland and listed on the Euronext Growth Dublin. For more information visit www.malinplc.com

For further information contact:


Jessica Bergin, Investor Relations & External Reporting

Tel: +353 (0)1 901 5700


Davy Corporate Finance (Euronext Growth Adviser & Joint Broker)

Brian Garrahy / Daragh O'Reilly

Tel: +353 1 679 6363

Liberum (Joint Broker)

Bidhi Bhoma / Euan Brown

Tel: +44 (0) 20 3100 2000

Powerscourt (Media enquiries)

Rory Godson / Eavan Gannon

Tel: +44 7909 926020 / +353 87 236 5973


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.



(END) Dow Jones Newswires

October 13, 2021 09:10 ET (13:10 GMT)

1 Year Malin Chart

1 Year Malin Chart

1 Month Malin Chart

1 Month Malin Chart
ADVFN Advertorial
Your Recent History
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V:gb D:20211202 04:11:23